企業プロフィール
Fresenius Medical Care Ventures 株価・ニュース・カタリスト
- ティッカー:
- FMS
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- Germany and listed in the U
株価パフォーマンス
23.50 USD (-1.14%)
終値
最終更新: 2026年8月17日
11B USD
時価総額
株価変動の要因
As of Aug 17, 2026, FMS closed down 1.14% at $23.50. No new same-company headline was identified in the current news window.
企業概要
事業概要
Fresenius Medical Care is a global dialysis and kidney-care company focused on renal services, dialysis products, and related healthcare infrastructure. Its business is built around treating chronic kidney disease at scale.
所在地とセクター分類
Headquartered in Germany and listed in the U.S. as an ADR, Fresenius Medical Care has a global operating footprint. It sits in healthcare services and dialysis, not biotechnology.
ビジネスモデルの特徴
The company generates revenue through dialysis treatments, care services, and medical products used in renal care. Investors focus on reimbursement, patient volume, treatment economics, and operational efficiency.
バイオ業界での位置付け
Fresenius Medical Care is not a biotech name, but it matters to healthcare investors because it sits in a critical chronic-care segment. Its stock is driven by utilization and reimbursement rather than trial data.
今後のカタリスト
- Fresenius Medical Care’s catalysts are dialysis margin recovery, care-delivery efficiency, and any update on the turnaround plan. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。